R. Wigand

3.3k total citations
167 papers, 2.6k citations indexed

About

R. Wigand is a scholar working on Genetics, Molecular Biology and Infectious Diseases. According to data from OpenAlex, R. Wigand has authored 167 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 129 papers in Genetics, 75 papers in Molecular Biology and 48 papers in Infectious Diseases. Recurrent topics in R. Wigand's work include Virus-based gene therapy research (127 papers), Viral Infectious Diseases and Gene Expression in Insects (59 papers) and Viral gastroenteritis research and epidemiology (44 papers). R. Wigand is often cited by papers focused on Virus-based gene therapy research (127 papers), Viral Infectious Diseases and Gene Expression in Insects (59 papers) and Viral gastroenteritis research and epidemiology (44 papers). R. Wigand collaborates with scholars based in Germany, United States and Sweden. R. Wigand's co-authors include Th. Adrian, John C. Hierholzer, Göran Wadell, Albert B. Sabin, Thomas E. Adrian, Heinz Bauer, J.C. de Jong, A G Wermenbol, Hans Gelderblom and Larry J. Anderson and has published in prestigious journals such as Nature, American Journal of Epidemiology and Journal of Clinical Microbiology.

In The Last Decade

R. Wigand

162 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Wigand Germany 25 2.0k 1.1k 1.0k 744 452 167 2.6k
Alistair H. Kidd Sweden 28 1.5k 0.7× 1.1k 1.0× 674 0.6× 959 1.3× 459 1.0× 48 2.4k
Jon-Duri Tratschin Switzerland 28 1.4k 0.7× 1.0k 0.9× 977 0.9× 345 0.5× 833 1.8× 42 2.9k
Matilda Benyésh-Melnick United States 31 693 0.3× 571 0.5× 514 0.5× 1.9k 2.5× 269 0.6× 83 2.7k
H. C. Turner United States 24 931 0.5× 617 0.5× 621 0.6× 792 1.1× 84 0.2× 50 2.4k
Gerald W. Both Australia 27 1.1k 0.5× 565 0.5× 1.1k 1.1× 413 0.6× 166 0.4× 57 2.1k
Kendall O. Smith United States 26 611 0.3× 537 0.5× 642 0.6× 930 1.3× 61 0.1× 85 2.0k
Erik S. Barton United States 19 785 0.4× 912 0.8× 424 0.4× 681 0.9× 154 0.3× 26 2.0k
K. K. Takemoto United States 25 435 0.2× 355 0.3× 333 0.3× 333 0.4× 204 0.5× 56 1.7k
Angelique A. C. Lemckert Netherlands 23 1.9k 1.0× 880 0.8× 1.3k 1.3× 501 0.7× 152 0.3× 33 2.7k
Jerome Custers Netherlands 19 1.3k 0.6× 757 0.7× 1.1k 1.0× 401 0.5× 124 0.3× 33 2.2k

Countries citing papers authored by R. Wigand

Since Specialization
Citations

This map shows the geographic impact of R. Wigand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Wigand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Wigand more than expected).

Fields of papers citing papers by R. Wigand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Wigand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Wigand. The network helps show where R. Wigand may publish in the future.

Co-authorship network of co-authors of R. Wigand

This figure shows the co-authorship network connecting the top 25 collaborators of R. Wigand. A scholar is included among the top collaborators of R. Wigand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Wigand. R. Wigand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wigand, R. & Th. Adrian. (1991). A rational system for classifying and denominating adenovirus genome types. Research in Virology. 142(1). 47–56. 4 indexed citations
2.
Adrian, Thomas E. & R. Wigand. (1991). Restriction Site Mapping of Subgenus D Adenoviruses, Prototypes 42–47, Intermediate and Atypical Strains. Zentralblatt für Bakteriologie. 276(1). 107–119. 2 indexed citations
3.
Adrian, Thomas E., et al.. (1990). Restriction site mapping of adenovirus type 8 genome types. Research in Virology. 141(6). 611–624. 22 indexed citations
4.
Adrian, Th., et al.. (1989). Genome type analysis of adenoviruses: isolates from one year from the Hannover area. Archives of Virology. 105(1-2). 89–101. 15 indexed citations
5.
Adrian, Thomas E. & R. Wigand. (1989). Genome type analysis of adenovirus 31, a potential causative agent of infants' enteritis. Archives of Virology. 105(1-2). 81–87. 22 indexed citations
6.
Wigand, R. & Th. Adrian. (1989). Intermediate adenovirus strains of subgenus D occur in extensive variety. Medical Microbiology and Immunology. 178(1). 37–44. 14 indexed citations
7.
Adrian, Th., et al.. (1989). Nosocomial and Endemic Infections with a Genome Type of Adenovirus Type 5. Zentralblatt für Bakteriologie. 271(3). 339–344. 2 indexed citations
8.
Wigand, R., et al.. (1988). The epidemiology of the human rabies threat in the grand duchy of Luxembourg. Annales de l Institut Pasteur Virologie. 139(1). 113–122.
9.
Adrian, Th., Gertrud Schäfer, Marion K. Cooney, J. P. Fox, & R. Wigand. (1988). Persistent enteral infections with adenovirus types 1 and 2 in infants: no evidence of reinfection. Epidemiology and Infection. 101(3). 503–509. 33 indexed citations
10.
Hierholzer, John C., R. Wigand, & J.C. de Jong. (1988). Evaluation of Human Adenoviruses 38, 39, 40, and 41 as New Serotypes. Intervirology. 29(1). 1–10. 15 indexed citations
11.
Adrian, Th., et al.. (1985). Characterization of Adenovirus 15/H9 Intermediate Strains. Intervirology. 23(1). 15–23. 27 indexed citations
12.
Jong, J.C. de, R. Wigand, Th. Adrian, et al.. (1984). Adenovirus 38: a New Human Adenovirus Species of Subgenus D. Intervirology. 22(3). 164–169. 9 indexed citations
13.
Kuhn, J, et al.. (1984). Laboratoriumspraxis bei Adenoviren. Zentralblatt für Bakteriologie Mikrobiologie und Hygiene 1 Abt Originale A Medizinische Mikrobiologie Infektionskrankheiten und Parasitologie. 257(3). 426–432. 3 indexed citations
14.
Wigand, R.. (1980). Age and susceptibility of Swiss mice for mouse adenovirus, strain FL. Archives of Virology. 64(4). 349–357. 11 indexed citations
15.
Wigand, R., et al.. (1979). [Virological diagnosis of epidemic keratoconjunctivitis (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 245(3). 395–408. 2 indexed citations
16.
Wigand, R., et al.. (1976). Laboratory procedures in adenoviruses. III. Sensitivity and specificity of serological tests (author's transl).. PubMed. 234(4). 14–24. 1 indexed citations
17.
Wigand, R., et al.. (1969). Neutralization of adenoviruses by component antisera. Archives of Virology. 27(1). 112–114. 9 indexed citations
18.
Wigand, R., et al.. (1967). [Replication of group II adenovirus in HeLa cells].. PubMed. 21(1). 1–10. 4 indexed citations
19.
Wigand, R., et al.. (1966). Virus-associated and soluble adenovirus hemagglutinins: Differences in antigenic specificity. Virology. 28(3). 484–485. 11 indexed citations
20.
Wigand, R. & Albert B. Sabin. (1962). Properties of epidemic strains of ECHO type 9 virus and observations on the nature of human infection. Archives of Virology. 11(5). 683–707. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026